A SYSTEM FOR VISUAL DATA ANALYSIS OF ULTRASOUND EXAMINATIONS WITH AND WITHOUT A CONTRAST MEDIUM, FOR EARLY AUTOMATED DIAGNOSTICS OF PANCREATIC PATHOLOGIES

Information

  • Patent Application
  • 20230281803
  • Publication Number
    20230281803
  • Date Filed
    July 16, 2021
    3 years ago
  • Date Published
    September 07, 2023
    a year ago
Abstract
We present a system and method for analysis of image and data of ultrasound and ultrasound with contrast medium of human pancreatic tissues to automatically diagnose acute pancreatitis of the pancreas and identify pancreatic non-viable tissues at an early stage. The system consists of a diagnostic ultrasound system with specialized software for contrast studies (ultrasound) for in vivo ultrasound examinations of human internal organs, recording reflected ultrasound signals from pancreatic tissues (without contrast material and when contrast material is injected) and an image and data processing algorithm with artificial intelligence (neural network) elements providing a diagnostic estimate of a recommendatory nature.
Description
TECHNICAL FIELD

The invention belongs to the field of medical equipment, and specifically—data analysis of ultrasound images as well as ultrasound images using the contrast medium. This is a system and a method for the automatised early diagnostics of pancreatic pathology and pancreatic necrosis. This description presents a system and a method for the automatised early diagnostics of acute pancreatitis in humans.


STATE OF THE ART

The ultrasound examination of the pancreatic tissue and the ultrasound examination with a contrast medium is one of the most accessible, safest (not involving the ionising radiation) and cheapest imaging methods to assess the condition of pancreas as well as adjacent tissues and other abdominal organs. This method allows assessment of the changes characteristic for acute pancreatitis in the pancreas and other organs as well as pancreatitis-associated local complications. The contrast media used during the ultrasound examinations are considered the safest ones; differently from the contrast media used during CT and MRI scans, they are not associated with the nephrotoxic effect. Ultrasound examination with the contrast medium allows both qualitative and quantitative real-time assessment of tissue perfusion (dynamic examination).


Methods of automatised processing of medical image and data provide added value and information for diagnosis-related decision making.


The document of USA patent US2015/0201907 contains a description of the method indicated for automatised detection of fluid effusion in the diagnostic ultrasound images of human abdomen. Effusion of fluids occurs because of internal bleeding. The suggested method is intended for automatised detection of liver and kidney location as well as aggregates of effused fluids using the procedures for processing of digital ultrasound images.


Patent application WO2017/075509 has disclosed the application of the non-invasive diagnostics technologies based on different physical principles (including ultrasound) and the use of the classifier installed in the software for automatised detection of a breast neoplasm.


Patent EP3510917 mentions the application of artificial intelligence (machine learning) for the automatised detection of the informative area in the images of human optical coherence tomography.


The patent US2014/0185895 document describes automatised detection of the informative area contour of the abdominal tissues of the human foetus in the diagnostic ultrasound images. As well as creation of a statistical model, involving characteristic features of the ultrasound images.


The patent US2018/0276821 document discloses the automatised detection and classification of liver neoplasms in the contrast-enhanced ultrasound (CEUS) diagnostic images. An automated analysis of image informative area is carried out at time intervals and at a spatial resolution. In addition, provision of a clinical decision support functionality for diagnostics applying a classifier installed in the software.


Acute pancreatitis diagnostics algorithm and application of ultrasound technique has been described in the documents of patents RU2649528 and RU2622611.


The automated solutions for non-invasive diagnostics of human internal organs described in the above-mentioned document have certain limitations as compared with the solutions disclosed in this description:

    • a) the informative area of the pancreas in the ultrasound diagnostic images with and without a contrast medium is detected only applying manual approach based on radiologist's experience, automation option is not available;
    • b) aiming to compensate the artefacts in the images caused by the physiological movements (e.g., patient's breathing, blood vessel pulsation) and positioning of the ultrasonic transducer array (such as movement of the investigator during the recording) correction of the selected contour is made only manually based on the experience of a physician radiologist. Automation option is not available;
    • c) the areas of healthy (viable) pancreatic tissues and the areas of pathological tissues (such as necrosis caused by the development of acute pancreatitis or a malignant tumour) are assessed only visually. Automated assessment of spatial quantitative tissue viability estimate in the regions of viable tissues and the regions of pathological tissues is not possible.
    • d) automated qualitative assessment of the dynamics of pancreatic tissue perfusion applying the comparative analysis in the pancreatic volume, aorta and the superior mesenteric artery has not been carried out.


Our invention describes a system and a method for automated analysis of diagnostic images and data of human pancreas affected by acute pancreatitis obtained by the ultrasound imaging technique with and without a contrast media. As a result of ultrasound examination with and without a contrast media an added value of automated clinical decision support is obtained involving automatised quantitative assessment of the viability pancreatic tissue and dynamics of perfusion in the examined pancreatic area.


The obtained quantitative information facilitates and accelerates the final clinical diagnosis making process for the acute pancreatitis and other pathologies as well as planning of possible surgical or radiological interventions or further treatment tactics. Up to now, such functionality during the ultrasound examination with and without a contrast medium for the diagnostics of pancreatic pathology was not available.


SUMMARY OF THE INVENTION

The described system and method intended to detect the signs of pancreatic pathology and pathologically altered pancreatic tissue, and more specifically—a system and a method for the collection and automated analysis of images and data of ultrasound and contrast ultrasound examination. The system consists of diagnostic ultrasound device with a software for the visualisation and processing of the information of a contrast ultrasound examination (2), carried out using the corresponding ultrasound transducers (1). Also, a database of a hospital information system (3), containing the collected and stored digital images and data of ultrasound examinations with and without a contrast medium. A workstation of the investigating physician for ultrasound image review or a diagnostic ultrasound device (4), designed for the review and analysis of digital images and data of ultrasound examinations and contrast ultrasound examinations with installed specialised software (5) and algorithms for the analysis of ultrasound images and data of human pancreas (collected in the database of hospital's information system (3)). Also, for automated assessment of informative quantitative parameters and automated comparison (using a classifier) with the database of characteristic images and parameters (6), for the assessment of estimates of pancreatic tissue damage and early diagnosis of acute pancreatitis. Classification result: no necrosis lesions, low, moderate or high-level necrosis lesions.


A system for analysis of ultrasound examination and contrast ultrasound examination images and data ensures early automated diagnosis of acute pancreatitis and detection of non-viable pancreatic tissues applying an artificial intelligence (different neural networks—mono-layer, multiple layer, deep learning, supervised, non-supervised etc.) and the classifier algorithms installed in the specialised software (5).





BRIEF DESCRIPTION OF THE DRAWINGS


FIG. 1. A scheme of the system for analysis of images and data of ultrasound examination and contrast ultrasound examination for automated early diagnosis of acute pancreatitis and pancreatic necrosis applying an artificial intelligence (different neural networks) and the classifier algorithms, with its components.



FIG. 2. A sequence of the processing steps of the images and data obtained during an ultrasound examination and a contrast ultrasound examination.





THE MOST SUITABLE IMPLEMENTATION OPTIONS

A system for the analysis of data and images of ultrasound examinations with and without a contrast media intended for the automated acute diagnosis of acute pancreatitis and pancreatic necrosis applying the algorithms of artificial intelligence (neural networks) described in this document has been designed for physicians-radiologists and professionals of other areas involved in such examinations. The system consists of the following devices (FIG. 1)



1—An array of ultrasound traducers (1);



2—Diagnostic ultrasound system with a specialised software for the examinations with a contrast medium (2);



3—A hospital information system with a database for storing of ultrasound images (3);



4—A computer intended for the review and processing of the ultrasound images (4);



5—A specialised software for the processing of ultrasound images and data with and without a contrast medium (5);



6—A database of characteristic images and parameters (6);


A non-invasive imaging of the structure of pancreatic tissues is carried out suing a diagnostic ultrasound system (2) with an array of ultrasound transducers (1). The registered and digitalised ultrasound images and data are stored in the database of hospital information system (3). A computer (4) intended for the review and analysis of the digitised ultrasound images and data. A computer (4) with installed specialised software (5) and algorithms is intended for automated analysis of ultrasound images and data of the human pancreas (collected in the database of hospital information system (3)). The algorithms for automated early diagnostics of acute pancreatitis and pancreatic necrosis that are installed in the specialised software (5) are applied in the following main stages (FIG. 2):


1. A diagnostic ultrasound system (2) with an array of ultrasound transducers (1) uploading the recorded images and data of the pancreatic ultrasound examinations with and without a contrast medium from the data base of hospital information system (3);


2. Detection of the informative area (C) in the diagnostic images (A) applying the algorithms of artificial intelligence (neural networks);


3. An automated detection and tracing of informative area in the diagnostic ultrasound images by adaptive correction of a contour of data selection area (D), aiming to eliminate the artefacts in the images caused by the physiological movements (e.g., patient's breathing, blood vessel pulsation) and positioning of the ultrasonic transducers array (such as movement by the investigating physician);


4. Establishment of spatial quantitative pancreatic tissue viability in the pancreatic volume using the ultrasound diagnostic images with a contrast medium (B). The detection and assessment is performed based on the wave reflection levels from the area of viable pancreatic tissues vs those from pathological tissue area (e.g. damaged by necrosis caused by acute pancreatitis or due to malignant neoplasm development). The adaptive thresholding algorithms are used to define the levels (Otsu et al.). The area (E) of necrosis region S1=X% and a set of quantitative parameters describing the region are calculated: Sp=[s1, s2, s3 . . . sN]. The area of healthy (viable) pancreatic tissues (F) S2=Y% and a set of quantitative parameters describing the region are also calculated: Sg=[s1, s2, s3 . . . sN];


5. A quantitative determination of perfusion dynamics in the viable pancreatic tissues in the ultrasound images with a contrast medium (B) by assessing the change in time of the amplitudes of the reflected ultrasound waves (integrated in the detected area of pancreatic contour) (G), after the injection of contrast medium. A normal log-distribution or other distribution model is used for the determination of the curve of perfusion dynamics. A position of peak value, ascending and descending curve slopes, dynamics of contrast medium inflow and outflow in the informative regions as well as other parameters are analysed. After obtaining the curve of perfusion dynamics (G), a comparison with perfusion dynamic in the viable part of the pancreas (if present) and in aorta and in superior mesenteric artery is carried out. A set of quantitative parameters describing the perfusion dynamics is also defined: Pg=[p1, p2, p3 . . . pN];


6. The pancreatic ultrasound images with and without a contrast medium and the defined set of quantitative parameters (S1, S2, Sp, Sg and Pg) are compared with the images characteristic for an acute pancreatitis and the parameters from the database (6);


7. Detection of the signs of acute pancreatitis as well as of viable and non-viable pancreatic tissues (necrosis) applying the classification algorithm installed in the specialised software (5). A database of characteristic images and parameters is used for algorithm training (6);

Claims
  • 1. A method of analysis of ultrasound images and data of pancreatic tissue for automated diagnosis of pancreatic pathologies, the method comprising: presenting the images of the reflected ultrasound wave amplitude distribution in the pancreatic tissue in grey scale and contrast medium regimens;detecting a contour of the pancreatic region;creating a multidimensional data module;processing the multidimensional data module using a database of characteristic images and parameters and applying a specialised artificial intelligence softwareclassifying level of necrosis in pancreatic tissue.
  • 2. The method of claim 1, comprising: a) creating the database for collection and storage of characteristic pancreatic images obtained by the diagnostic ultrasound system under grey scale and contrast medium regimens;b) emitting ultrasound waves by the diagnostic ultrasound system to the patient's pancreatic region and registration of 2D images of pancreatic sections under grey scale and contrast medium regimens;c) storing the registered 2D images of pancreatic sections obtained in grey scale and contrast medium regimens in the database;d) processing of 2D images of pancreatic sections obtained in grey scale and contrast medium regimens in a computer with the specialised artificial intelligence software, obtaining values of the multidimensional data module;e) detecting the contour of the pancreatic region by applying the the specialised artificial intelligence software.
  • 3. The method of claim 1, wherein processing the multidimensional module further comprises automated detection of the contour of the pancreatic region in ultrasound examination images and in diagnostic contrast ultrasound examination images, applying adaptive correction of the contour of data selection region to eliminate the artifacts in the images caused by the physiological movements and positioning of the ultrasonic transducers array during the ultrasound examination.
  • 4. The method of claim 1, wherein processing the multidimensional module further comprises establishing spatial quantitative pancreatic tissue viability in the pancreatic volume using ultrasound diagnostic images with a contrast medium, is performed on the basis of the wave reflection levels from the area of viable pancreatic tissues as compared to wave reflection levels from pathological tissue area.
  • 5. The method of claim 1, wherein processing the multidimensional module further comprises calculating the area of a region of necrotic pancreatic tissue, calculating a set of quantitative parameters describing the region, and calculating the area of the region of viable pancreatic tissue, and calculating a set of quantitative parameters describing the region.
  • 6. The method of claim 1, wherein processing the multidimensional module further comprises: determining perfusion dynamics in the viable pancreatic tissues in the ultrasound images with a contrast medium by assessing the change in time of the amplitudes of the reflected ultrasound waves, such that the detected area of the pancreatic contour is integrated, after the injection of contrast medium; andcalculating a set of quantitative parameters describing the dynamics of pancreatic perfusion based on the integration of the detected area of the pancreatic contour.
  • 7. The method of claim 1, wherein processing the multidimensional module further comprises comparing the perfusion dynamics in the viable pancreatic tissues and in aorta and in superior mesenteric artery.
  • 8. (canceled)
  • 9. The method of claim 1, wherein a diagnostic ultrasound system is configured in a way that the imaging window accommodates the whole patient's pancreas during the examination.
Priority Claims (1)
Number Date Country Kind
LT2020 538 Jul 2020 LT national
PCT Information
Filing Document Filing Date Country Kind
PCT/IB2021/056443 7/16/2021 WO